Long-term outcome of simultaneous septal myectomy and anterior mitral leaflet retention plasty in hypertrophic obstructive cardiomyopathy: the Berlin experience

Walter, Eva Maria Delmo; Javier, Mariano Francisco del Maria; Hetzer, Roland

doi:10.21037/acs.2017.03.08

Cited by 9 publications

(3 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…During follow up NYHA class reduced, the number of maintenance drugs decreased, reduction in LVOT gradient, and SAM was abolished. Two patients however needed immediate MV replacement due to severe residual MR post operatively 28 . Dulguerov et al performed SM followed by MV repair by increasing AML height and decreasing PML height.…”

Section: Surgical Myectomymentioning

confidence: 99%

Alcohol septal ablation: A useful tool in our arsenal against hypertrophic obstructive cardiomyopathy

Savarimuthu

Harky

2020

J Card Surg

View full text Add to dashboard Cite

Objective Affecting 1 in 500 individuals; hypertrophic cardiomyopathy is an autosomal dominant cardiovascular disorder which is prevalent throughout the world. Surgical myectomy (SM) and alcohol septal ablation (ASA) are two methods currently used for the management of drug refractory hypertrophic obstructive cardiomyopathy (HOCM). ASA may prove to be a useful, less invasive treatment in patients with HOCM Methods Electronic literature search was conducted to identify articles that discussed methods to treat drug refractory HOCM. No limits were placed on timing of the publication or the type of article. Keywords and MeSH terms were used and the results were summarized in the relevant section. Results Current evidence suggests that alcohol septal ablation is a safe and effective procedure in treating patients with HOCM with similar short‐ and long‐term outcomes when compared with SM. Conclusion ASA has been shown to be a safe and reliable procedure; imaging techniques and dedicated multi‐disciplinary teams can be used to select patients with HOCM. Though SM is recommended as gold standard treatment for drug refractory HOCM, ASA may play an increasing role in the near future due an ageing population; both ASA and SM can have a beneficial role in treating those who are affected by HOCM when the appropriate group of patients are selected for each intervention.

show abstract

Section: Surgical Myectomymentioning

confidence: 99%

Alcohol septal ablation: A useful tool in our arsenal against hypertrophic obstructive cardiomyopathy

Savarimuthu

Harky

2020

J Card Surg

View full text Add to dashboard Cite

show abstract

“…Изолированной МЭ зачастую недостаточно для полного устранения обструкции ВТЛЖ из-за сохраняющегося переднего систолического движения МК за счет изменения Результаты хирургического лечения ГКМП [33][34][35][36][37][38] Results of surgical treatment of HCM [33][34][35][36][37][38] Автор, клиника…”

Section: хирургическое лечениеunclassified

Hypertrophic cardiomyopathy: current state of the problem

Lednev

Stonogin

Lysenko

et al. 2019

Khir. Z. im. N.I. Pirogova

View full text Add to dashboard Cite

Во второй половине XX века произошла существенная эволюция знаний о гипертрофической кардиомиопатии. Об этом можно судить и по изменению терминологии, используемой для обозначения этого заболевания,-от функционального аортального стеноза к идиопатическому ги-пертрофическому аортальному стенозу, гипертрофической обструктивной кардиомиопатии и, наконец, гипертрофической кардиомиопатии (ГКМП). Последний термин является наиболее объективным, указывая на то, что обструкция выходного тракта левого желудочка (ВТЛЖ) не явля

show abstract

“…They concluded that ALRP sustained absence of SAM, absence of residual LVOT obstruction, and improvement in hemodynamic and functional statuses. 27) …”

Section: Introductionmentioning

confidence: 99%

Surgical Management for Systolic Anterior Motion (SAM) of the Mitral Valve in Obstructive Hypertrophic Myopathy

Usui

Mutsuga

2022

ATCS

View full text Add to dashboard Cite

In patients with obstructive hypertrophic cardiomyopathy, left ventricular outflow tract (LVOT) obstruction can be created by the hypertrophic interventricular septum (IVS) as well as systolic anterior motion (SAM) of the anterior mitral leaflet (AML). Sufficient septal myectomy is a fundamental surgical technique to treat LVOT obstruction, however, direct surgical management for SAM is another key aspect. Besides the hypertrophic IVS, mitral valve, subvalvular apparatus, and papillary muscle may play important role for SAM and several surgical techniques have been proposed to treat SAM in literature. In this review, each surgical technique is classified by the anatomical structure on which the surgical procedure is applied. The AML is the main surgical site and is applied with plication (vertical plication, resection–plication–release strategy), extension (the AML extension, transverse incision of the AML), sutured (edge-to-edge repair, anterior leaflet retention plasty), or traction (floating stitch, papillary muscle-to-anterior annulus stitches, paradoxical stitches, transposition of a directed chorda tendinea to the AML). Height reduction of the posterior mitral valve leaflet and papillary muscle reorientation are other techniques. We should understand theoretical aspects of each technique on correction of anatomical and functional abnormalities of the structure and should apply them under proper indication.

show abstract

Long-term outcome of simultaneous septal myectomy and anterior mitral leaflet retention plasty in hypertrophic obstructive cardiomyopathy: the Berlin experience

Cited by 9 publications

References 21 publications

Alcohol septal ablation: A useful tool in our arsenal against hypertrophic obstructive cardiomyopathy

Alcohol septal ablation: A useful tool in our arsenal against hypertrophic obstructive cardiomyopathy

Hypertrophic cardiomyopathy: current state of the problem

Surgical Management for Systolic Anterior Motion (SAM) of the Mitral Valve in Obstructive Hypertrophic Myopathy

Contact Info

Product

Resources

About